Back
Rocket Pharmaceuticals Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
48
RCKT
Rocket Pharmaceuticals
Last Price:
22.56
Seasonality Move:
12.54%
Buy
55
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
37.54
Seasonality Move:
-15.12%
Sell
48
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
- The current Rocket Pharmaceuticals [RCKT] share price is $22.52. The Score for RCKT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- RCKT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $37.25. The Score for CRBP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $22.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight buying pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $37.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing slight selling pressure.
RCKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.17 | Sell |
| Relative Strength Index (14 RSI): | 38.6 | Sell |
| Chaikin Money Flow: | 3050 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.66 - 25.74) | Sell |
| Bollinger Bands (100): | (25.06 - 29.66) | Sell |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 50.46 | Buy |
| Chaikin Money Flow: | -42000 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.86 - 40.12) | Sell |
| Bollinger Bands (100): | (10.43 - 38.95) | Buy |
RCKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.65 | Sell |
| 20-day SMA: | 23.65 | Sell |
| 50-day SMA: | 26.14 | Sell |
| 200-day SMA: | 23.11 | Sell |
| 8-day EMA: | 22.54 | Sell |
| 20-day EMA: | 23.63 | Sell |
| 50-day EMA: | 25.27 | Sell |
| 200-day EMA: | 24.13 | Sell |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.09 | Buy |
| 20-day SMA: | 38.05 | Sell |
| 50-day SMA: | 37.07 | Buy |
| 200-day SMA: | 15.38 | Buy |
| 8-day EMA: | 36.54 | Buy |
| 20-day EMA: | 37.23 | Buy |
| 50-day EMA: | 34.53 | Buy |
| 200-day EMA: | 20.28 | Buy |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.26 per share, an increase this year of $0.38 per share, and an increase next year of $0.83 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.66 per share, and an increase next year of $0.09 per share.
Rocket Pharmaceuticals Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||